Human Molecular Genetics, 2002, Vol. 11, No. 7 815-821
© 2002 Oxford University Press
Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro
Center for Molecular Medicine, 1Clinic III for Internal Medicine and 2Center for Physiology and Pathophysiology, University of Cologne, Germany, 3German Institute for Human Nutrition (DIfE) and Free University of Berlin, Germany, 4Harvard Medical School, Joslin Diabetes Center, Boston, MA, USA, 5Diabetes-Research Institute (DFI), Department of Biochemistry, Düsseldorf, Germany and 6Institute of Biochemistry, Swiss Federal Institute of Technology (ETH), Zürich, Switzerland
Friedreich ataxia is an inherited disorder caused by decreased expression of frataxin protein. Increasing evidence suggests that this protein might detoxify reactive oxygen species (ROS) by an unknown mechanism. Here we demonstrate that transgenic overexpression of human frataxin increases cellular antioxidant defense via activation of glutathione peroxidase and elevation of reduced thiols, thereby reducing the incidence of malignant transformation induced by ROS, as observed by soft agar assays and tumour formation in nude mice. These findings expand the understanding of antioxidant properties of frataxin, and tentatively suggest a role in the early induction of cancer.
+ To whom correspondence should be addressed at: German Institute of Human Nutrition, DIfE, KLE, 114, Arthur-Scheunert-Allee, 14558 Potsdam-Rehbrücke, Germany. Tel: +49 33200 88 787; Fax: +49 33200 88 777; Email: mristow@mristow.org Present address: Sarah A. Shoichet, Max-Planck-Institute (MPI) for Molecular Genetics, Berlin, Germany
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
O. Gakh, D. Y. Smith IV, and G. Isaya Assembly of the Iron-binding Protein Frataxin in Saccharomyces cerevisiae Responds to Dynamic Changes in Mitochondrial Iron Influx and Stress Level J. Biol. Chem., November 14, 2008; 283(46): 31500 - 31510. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zarse, T. J. Schulz, M. Birringer, and M. Ristow Impaired respiration is positively correlated with decreased life span in Caenorhabditis elegans models of Friedreich Ataxia FASEB J, April 1, 2007; 21(4): 1271 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Llorens, J. A. Navarro, M. J. Martinez-Sebastian, M. K. Baylies, S. Schneuwly, J. A. Botella, and M. D. Molto Causative role of oxidative stress in a Drosophila model of Friedreich ataxia FASEB J, February 1, 2007; 21(2): 333 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Condo, N. Ventura, F. Malisan, B. Tomassini, and R. Testi A Pool of Extramitochondrial Frataxin That Promotes Cell Survival J. Biol. Chem., June 16, 2006; 281(24): 16750 - 16756. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Schulz, R. Thierbach, A. Voigt, G. Drewes, B. Mietzner, P. Steinberg, A. F. H. Pfeiffer, and M. Ristow Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibits Cancer Growth: OTTO WARBURG REVISITED J. Biol. Chem., January 13, 2006; 281(2): 977 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lu, C. L. Dalgard, A. Mohyeldin, T. McFate, A. S. Tait, and A. Verma Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1 J. Biol. Chem., December 23, 2005; 280(51): 41928 - 41939. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Thierbach, T. J. Schulz, F. Isken, A. Voigt, B. Mietzner, G. Drewes, J.-C. von Kleist-Retzow, R. J. Wiesner, M. A. Magnuson, H. Puccio, et al. Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice Hum. Mol. Genet., December 15, 2005; 14(24): 3857 - 3864. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gariboldi, M. Spinola, S. Milani, C. Pignatiello, K. Kadota, H. Bono, Y. Hayashizaki, T. A. Dragani, and Y. Okazaki Gene expression profile of normal lungs predicts genetic predisposition to lung cancer in mice Carcinogenesis, November 1, 2003; 24(11): 1819 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tan, E. Napoli, F. Taroni, and G. Cortopassi Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells Hum. Mol. Genet., July 15, 2003; 12(14): 1699 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Jauslin, T. Wirth, T. Meier, and F. Schoumacher A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy Hum. Mol. Genet., November 15, 2002; 11(24): 3055 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pianese, L. Busino, I. De Biase, T. de Cristofaro, M. S. Lo Casale, P. Giuliano, A. Monticelli, M. Turano, C. Criscuolo, A. Filla, et al. Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells Hum. Mol. Genet., November 1, 2002; 11(23): 2989 - 2996. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Muhlenhoff, N. Richhardt, M. Ristow, G. Kispal, and R. Lill The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins Hum. Mol. Genet., August 15, 2002; 11(17): 2025 - 2036. [Abstract] [Full Text] [PDF] |
||||



